Hesperadin
Hesperadin is an ATP competitive indolinone inhibitor of Aurora A and B. Hesperadin inhibits Aurora B with an IC50 of 250 nM. Hesperadin inhibits the growth of Trypanosoma brucei by blocking nuclear division and cytokinesis. Hesperadin also is a broad-spectrum influenza antiviral[1][2][3].
Product Specifications
CAS Number
422513-13-1
UNSPSC
12352005
Hazard Statement
H302
Target
Aurora Kinase; Autophagy; Influenza Virus; Parasite
Type
Reference compound
Related Pathways
Anti-infection; Autophagy; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Hesperadin.html
Purity
98.89
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C1NC2=CC=C(C=C2/C1=C(NC3=CC=C(C=C3)CN4CCCCC4)\C5=CC=CC=C5)NS(CC)(=O)=O
Molecular Formula
C29H32N4O3S
Molecular Weight
516.65
Precautions
H302
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Aurora B; Trypanosoma
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Dcun1d5 sgRNA CRISPR Lentivector (Rat) (Target 3)
TRIM30 Polyclonal Antibody, AbBy Fluor™ 750 Conjugated
